(Q43283959)

English

Combined mycophenolate mofetil and minimal dose calcineurin inhibitor therapy in liver transplant patients: clinical results of a prospective randomized study

scientific article published in July 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Combined mycophenolate mofetil and minimal dose calcineurin inhibitor therapy in liver transplant patients: clinical results of a prospective randomized study (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

5

object named as

G Gerken

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Susanne Beckebaum

1

object named as

S Beckebaum

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Vito R. Cicinnati

7

object named as

V R Cicinnati

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Georgios C Sotiropoulos

3

object named as

G C Sotiropoulos

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

4

object named as

F H Saner

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

author name string

C G Klein

2

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

A Paul

6

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

language of work or name

0 references

publication date

1 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

2567-2569

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Long-term outcome of adding mycophenolate mofetil to tacrolimus for nephrotoxicity following liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.152

7 January 2021

Introduction of MMF in conjunction with stepwise reduction of calcineurin inhibitor in stable liver transplant patients with renal dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.152

7 January 2021

Efficacy of mycophenolate mofetil combined with very low-dose cyclosporine microemulsion in long-term liver-transplant patients with renal dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.152

7 January 2021

Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.152

7 January 2021

Mycophenolate mofetil monotherapy in liver transplant recipients: a single center experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.152

7 January 2021

Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.152

7 January 2021

Mycophenolate mofetil can be used as monotherapy late after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.152

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2009.06.152

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43283959&oldid=2070074546"